Loading…
Thursday, May 16 • 9:05am - 10:00am
Interventional Brain Medicine and Neuromodulation for Addiction

Log in to save this to your schedule, view media, leave feedback and see who's attending!

The session will explore cutting-edge approaches in treating addiction through innovative techniques targeting the brain's neural circuitry. This session delves into the intersection of interventional brain medicine, which encompasses minimally invasive procedures for neurological disorders, and neuromodulation, involving the precise modulation of neural activity. Speakers present research findings and clinical applications of these methodologies, highlighting their potential in addressing addiction by targeting specific brain regions and neural pathways. Discussions focus on the efficacy, safety, and ethical considerations of utilizing these interventions to combat substance use disorders, offering insights into the evolving landscape of addiction treatment.

Speakers
avatar for Michael Sprintz, DO, DFASAM

Michael Sprintz, DO, DFASAM

Expert on the Intersection of Chronic Pain and Addiction
Dr. Sprintz is a national expert on the intersection of chronic pain, addiction, and digital health technologies. He received his training at institutions including Johns Hopkins, and MD Anderson Cancer Center and is triple board-certified in Pain Medicine, Addiction Medicine, and... Read More →
avatar for Owen Muir, MD

Owen Muir, MD

Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists
Owen Scott Muir, MD Is a dual board-certified child, adolescent and adult psychiatrist, and co-author of Adolescent Suicide and Self-Injury: Mentalizing Theory and Treatment.  He has held academic appointments at Hofstra-Northwell, NYU and Baylor College of Medicine.  He is the... Read More →
avatar for Colleen A. Hanlon, PhD

Colleen A. Hanlon, PhD

Vice President, Medical & Clinical Affairs, Director, Innovation Team, BrainsWay Deep TMS
Dr. Hanlon is an internationally recognized thought-leader in the development and expansion of non-invasive neuromodulation therapeutics for addiction and has had a career that brought her from basic science research through FDA-pivotal clinical trials.  Now the Vice President of... Read More →


Thursday May 16, 2024 9:05am - 10:00am EDT
Feedback form isn't open yet.